The Pharmaceutical Project

Dicot Pharma is developing LIB-01 to be a next-generation erectile dysfunction treatment for the global market, aiming to surpass existing drugs. There is a significant medical need for new, improved treatments for erectile dysfunction. With longer duration, fewer side effects, and a differentiated mechanism of action, we aim to provide affected men and couples with an improved intimate life.